中国循证医学杂志

中国循证医学杂志

胸腔镜微创手术与开胸手术比较对胸腺瘤合并重症肌无力患者炎性反应的研究

查看全文

目的 探讨胸腔镜微创与开胸两种手术方式对胸腺瘤合并重症肌无力患者炎性反应的影响。 方法 纳入 2014 年 8 月至 2015 年 6 月接受手术治疗的 Masaoka Ⅰ 期或 Ⅱ 期的胸腺瘤合并重症肌无力患者,胸腔镜手术治疗组与传统开胸手术治疗组各 20 例。于麻醉前(T1)、麻醉后(T2)、切皮后 2 h(T3)、术后 24 h(T4)、术后 48 h(T5)和术后 72 h(T6)6 个时间点取外周静脉血,应用酶联免疫试剂盒(ELISA)检测 IL-6、IL-8、TNF-α、CRP、CORT 的浓度。记录患者围手术期一般临床资料。采用 SPSS 17.0 软件对数据进行统计分析。 结果 胸腔镜组和传统开胸组各相邻时间点炎性因子比较:IL-6、IL-8、TNF-α、CRP 和 CORT 的表达水平在 T1、T2 和 T3 三个时间点比较差异无统计学意义(P 值均>0.05);术后各因子水平比术前明显升高,T4 时间点达到峰值(P 值均<0.01),而后逐渐下降。T6 时间点除胸腔镜组 TNF-α 恢复至术前水平(P>0.05)外,胸腔镜组和传统开胸组其它各因子仍高于术前水平(P 值均<0.01)。胸腔镜组各因子在 T4、T5 和 T6 时间点明显低于传统开胸组(P 值均<0.05)。胸腔镜组手术时间、术后引流管留置时间、切口愈合时间明显少于开胸组(P 值均<0.05)。 结论 胸腔镜下胸腺瘤根治术可减少患者手术创伤,减轻炎性反应程度,具有较好的临床推广价值。

Objective To investigate the effects of inflammatory reaction of thymomas with myasthenia gravis (MG) treated by traditional thoracotomy and minimally invasive surgery. Methods A total of 40 thymomas patients (Mssaoka Ⅰ or Ⅱ) with myasthenia gravis from August 2014 to June 2015 were treated by traditional thoracotomy (n=20) or video-assisted thoracoscopic surgery (n=20). The serum levels of IL-6, IL-8, TNF-α, CRP and CORT were measured by enzyme-linked immunosorbent assay (ELISA) methods at before anesthesia (T1), after anesthesia (T2), 2 h after skin cut (T3), 24 h post-operation (T4), 48 h post-operation (T5) and 72 h post-operation (T6) respectively. Perioperative parameters were also reported. The statistics analysis was performed by SPSS 17.0 software. Results The serum levels of IL-6, IL-8, TNF-α, CRP and CORT had no significant difference between T1 and T2, T2 and T3 (allP value>0.05) in both groups. But the serum levels of these factors after operation were obviously higher than that of before operation, commonly the highest level was reached at T4 (allP value>0.01), and also was higher at T6 than that of before the operation (allP value<0.01), except the level of TNF-α recovered rapidly to the level of before operation (allP value>0.05) in the VATS group. The operation time, postoperative drainage tube indwelling time and incision healing time in the VATS were lower than that in the control group (allP value<0.05). Conclusion VATS could be widely applied in clinical practice with lowering operative trauma and reducing the degree of inflammatory reaction.

关键词: 胸腺瘤; 重症肌无力; 胸腔镜微创; 手术创伤; 炎性反应

Key words: Thymoma; Myasthenia gravis; Video-assisted thoracoscopic surgery (VATS); Operative trauma; Inflammatory reaction

引用本文: 孙培道, 杨玉赏, 胡伟鹏, 陈龙奇, 袁勇. 胸腔镜微创手术与开胸手术比较对胸腺瘤合并重症肌无力患者炎性反应的研究. 中国循证医学杂志, 2017, 17(4): 383-388. doi: 10.7507/1672-2531.201701035 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Rowse PG, Roden AC, Corl FM,et al. Minimally invasive thymectomy: the mayo clinic experience. Ann Cardiothorac Surg, 2015, 4(6): 519-526.
2. Muhammed J, Chen CY, Wan H,et al. Thymectomy for myasthenia gravis: a 10-year review of cases at the hospital university Sains Malaysia. Malays J Med Sci, 2016, 23(4): 71-78.
3. Diaz A, Black E, Dunning J. Is thymectomy in non-thymomatous myasthenia gravis of any benefit? Interact Cardiovasc Thorac Surg, 2014, 18(3): 381-389.
4. Hess NR, Sarkaria IS, Pennathur A,et al. Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes. Ann Cardiothorac Surg, 2016, 5(1): 1-9.
5. Coosemans W, Lerut TE, Van Raemdonck DE. Thoracoscopic surgery: the Belgian experience. Ann Thorac Surg, 1993, 56(3): 721-730.
6. Ng CS, Whelan RL, Lacy AM,et al. Is minimal access surgery for cancer associated with immunologic benefits? World J Surg, 2005, 29(8): 975-981.
7. Walker WS, Codispoti M, Soon SY,et al. Long-term outcomes following VATC lobectony for non-small cell bronchogenic carcinoma. Eur J Cardio-Thorac Surg, 2003, 23(3): 397-402.
8. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatr, 1989, 52(10): 1121-1127.
9. Liu CW, Luo M, Mei JD,et al. Perioperative and long-term outcome of thymectomy for myasthenia gravis: comparison of surgical approaches and prognostic analysis. Chin Med J (Engl), 2013, 126(1): 34-40.
10. Sablotzki A, Mann V, Simm A,et al. Changes in the cytokine net work through escalating SIRS after heart surgery. Anasthesiol Intensivmed Notfallmed Schmerzther, 2001, 36(9): 552-559.
11. Sakamoto K, Hisanob S, Kamoharab H,et al. Changes of interleukin 6 and soluble IL-6 receptor levels after surgery .International Congress Series, 2003, 125(5): 135-142.
12. Sakamoto K, Arakawa H, Mita S,et al. Elevation of circulating in terleukin 6 after surgery: factors influencing the serum level. Cytokine, 1994, 6(2): 181-186.
13. Van Zee KJ, Fischer E, Hawes AS,et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol, 1992, 148(6): 1746-1752.
14. Ohzato H, Yoshizaki K, Nishimoto N,et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of Interleukin-6 and C-reactive protein after surgery. Surgery, 1992, 111(2): 201-209.
15. Grande M, Tucci GF, Adorisio O,et al. Systemic acute-phase response after laparoscopic and open cholecystectomy. Surg Endosc, 2002, 16(2): 313-316.
16. 蒲强, 马林, 梅建东, 等. 全胸腔镜与后外侧开胸对肺癌患者免疫功能影响的对比研究. 四川大学学报(医学版), 2013, 44(1): 126-129.
17. Raza A, Woo E. Video-assisted thoracoscopic surgery versus sternotomy in thymectomy for thymoma and myasthenia gravis. Ann Cardiothorac Surg, 2016, 5(1): 33-37.
18. Zahid I, Sharif S, Routledge T,et al. Video-assisted thoracoscopic surgery or transsternal thymectomy in the treatment of myasthenia gravis? Interact Cardiovasc Thorac Surg, 2011, 12(1): 40-46.
19. Meyer DM, Herbert MA, Sobhani NC,et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches. Ann Thorac Surg, 2009, 87(2): 385-390.